Industry Satellite Symposia
This symposium is for healthcare professionals only, it is not open to patients or members of the public.
Thursday 6 June 2024 13:00–14:00 BST Armadillo | Broadening treatment horizons for people with cystic fibrosis | |
|---|---|---|
Chaired by: Panellists: | ||
13:00–13:10 | Chair’s opening remarks: | Prof. Jane Davies |
13:10–13:30 | CFTR function restoration: | Prof. Marcus Mall |
13:30–13:45 | Rare mutations: | Prof. Pierre Regis Burgel |
13:45–13:55 | The remaining 7%: | Prof. Jane Davies |
13:55–14:00 | Chair’s closing remarks | Prof. Jane Davies |
There will be the opportunity for questions throughout the symposium.
Objectives:
• Discuss the importance of restoring CFTR function
• Describe the challenges in developing therapies for pwCF with rare mutations
• Highlight current and future therapy innovations to potentially reach all pwCF
This symposium is for healthcare professionals only, it is not open to patients or members of the public.
Friday 7 June 2024 13:00–14:00 BST Armadillo | Adapting to the new era for people with cystic fibrosis | |
|---|---|---|
Chaired by: Speakers: | ||
13:00–13:10 | Chair’s opening remarks: | Prof. Isabelle Fajac |
13:10–13:20 | Setting new standards for the paediatric CF population | Dr Florian Stehling |
13:20–13:35 | Impact of longer life: | Dr Eva Polverino |
13:35–13:45 | Ensuring all patients are on the journey: | Dr Andrea Gramegna |
13:45–14:00 | Q&A and Chair’s closing remarks | All speakers, |
Objectives:
• Provide an overview of the achievements of the CF clinical community, underscored by improvements to CFTR function
• Educate on the importance of treating early and the impact this has on CFTR function and extrapulmonary outcomes
• Highlight the need for alternative approaches to monitor clinical outcomes
• Raise awareness of the areas of unmet need in the care of pwCF, including the need for holistic care of ageing adults living with CF, and appropriate management for pwCF who are ineligible for current treatment options